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January 11, 2011:220–2In all subjects, the peak p17 peptide level occurred after PCI and
as positively correlated with the peak cTnI (r  0.48, p  0.011)
nd peak CK-MB (r  0.56, p  0.002, Spearman for all) levels.
he correlations were not tight, suggesting that both necrosis and
poptosis play a role in determining infarct size. The use of this
ovel assay for the first time sets the stage to investigate this critical
alance. The rise and fall of p17 peptide and its correlation with
eak cTnI and CK-MB suggest that serum p17 likely came from
njured myocardium. A calpain (4) and stretch-mediated (5)
yocyte apoptosis may have also contributed to the serum p17
evel.
Limitations include the lack of concurrent myocyte evidence of
poptosis and unknown p17 release kinetics. Designing therapies
o inhibit apoptosis may provide benefit to STEMI patients.
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onsequently with a small final IS, the major adverse cardiac events
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Circulation 1993;87 Suppl VII:22–7.Letters to the Editoryocardial Salvage Index and
nfarct Size Represent Related
ut Distinct Components of
cute ST-Segment Elevation
yocardial Infarction
ne of the conclusions of Eitel et al. (1), that the myocardial salvage
ndex (MSI) assessed by cardiac magnetic resonance is the strongest
nverse correlate of major adverse cardiac events and mortality at
-month follow up (compared with infarct size [IS] alone measured in
he acute phase by late gadolinium enhancement by cardiovascular
agnetic resonance), is not supported by the data presented.
Inspection of the receiver-operating characteristic curves reveals
hat the predictive value of IS is similar to that indicated by the
SI (area under the curve: 0.791 vs. 0.803), and I suspect that it
ould be confirmed to be nonsignificant by appropriate statistical
nalysis comparing the 2 variables, which was not performed. This
s also expected from the large body of clinical evidence accumu-
ated thus far that final IS and consequently extent left ventricular
ysfunction determine the major adverse cardiac events and mor-
ality resultant from acute ST-segment elevation myocardial in-
arction (ASTEMI), as demonstrated by Larose et al. (2) in the
ame issue of the Journal, regardless of the extent of the MSI.
hus, if a large infarct was reperfused optimally with a large MSInd mortality would be similar to those of a small infarct
eperfused suboptimally with a small MSI but still a small final IS.
his is important because IS measurement (but not MSI) can be
imilarly accomplished by delayed contrast enhancement com-
uted tomography myocardial perfusion imaging with similar
ccuracy (from preliminary studies) (3) and myocardial contrast
chocardiography. Hence, this important prognostic variable could
ecome more rapidly and widely available clinically.
Their other conclusion that MSI determined by cardiac mag-
etic resonance provides the best clinical investigative tool to
easure success of therapies to limit IS in ASTEMI is of course
ntirely valid. More important, comparing the curve depicting the
elationship between the time to reperfusion and the MSI (that
hey have elegantly demonstrated) in control and treatment groups
s uniquely able to measure IS reduction in humans by therapeutic
easures to reduce reperfusion injury because this methodology
ontrols for the critical time to reperfusion variable in clinical
esearch in ASTEMI, which is the major determinant of MSI and
ence final IS. IS measurement alone in this research area would
e clearly inadequate. MSI by itself would be an excellent and
omprehensive measure of the effectiveness of an ASTEMI
eperfusion program superior to door-to-balloon time.
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eply
e thank Dr. Ramanna for his interest in our work. Our large
rospective study for the first time demonstrated that myocardial
alvage assessed by cardiac magnetic resonance predicts clinical
utcome in acute reperfused myocardial infarction patients (1).
ndeed, the myocardial salvage index (MSI) was the strongest
redictor of mortality and major adverse cardiac events (MACE)
ccording to our statistical analysis.
We performed a conditional stepwise Cox regression analysis
ith the candidate variables infarct size, microvascular obstruction,
SI, Thrombolysis In Myocardial Infarction flow grade after
ercutaneous coronary intervention, Killip class, left ventricular
jection fraction, and ST-segment resolution. After 3 steps, MSI
emained the only significant prediction factor for the combined
nd point. Furthermore, MSI had a better predictive value for
ortality than infarct size in our (unadjusted) receiver-operating
haracteristic curve analysis (0.818 vs. 0.701). The p value for the
omparison (not shown in the paper) is 0.02. For MACE,
owever, the difference was not statistically significant (0.803 vs.
.791, p  0.65). However, it should be kept in mind that the
statistic is relatively insensitive compared with more global
odels adjusting for other variables (such as the regression model
sed in the paper) (2). Thus, we feel confident to conclude that in
ur study of 208 infarction patients, MSI was the strongest
orrelate of mortality and MACE.Nevertheless, we agree with Dr. Ramanna that in myocardial
alvage assessment, it is indeed the final infarct size that can be
onsidered the true biological target of interest. We also believe
hat further studies are required to clarify the relationship between
he salvaged area at risk and clinical outcome.
We agree with Dr. Ramanna that myocardial salvage is a very
romising clinical investigative tool to test the efficacy of different
eperfusion therapies among patients with acute myocardial infarc-
ion. Infarct size reduction is suboptimal to assess the efficacy of
eperfusion therapy because the final infarct size depends on
ultiple factors such as the extent of the area at risk, collateral
lood flow, duration of myocardial ischemia, and metabolic de-
and (3). Therefore, measuring only infarct size might impose a
otential bias, and myocardial salvage with an adjustment for the
rea at risk may be a better surrogate end point in clinical trials.
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